Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
While preliminary tests indicate potential exposure to heroin and fentanyl, it is unclear how they were exposed
Medication-assisted treatment helps by moving a patient from powerful painkillers to a regular dose of a legal opioid-based medication
A DEA special agent said that acrylfentanyl has shown some possibility of being resistant to naloxone
David Reitz, 28, drove erratically until the 11-year-old child asked him to pull over
The report’s findings help identify when and where highly potent opioids are introduced into a community
Tianna Hollinside was taken to the hospital after paramedics performed CPR
An officer had to be revived with four doses of Narcan after he accidentally came into contact with fentanyl
The #BlufftonHeartsMatter campaign aims to place 30 AEDs in the town to create a safer community
What’s the evidence that delivery of dual defibrillation improves survival outcomes for patients who suffer out-of-hospital cardiac arrest and fail to respond to conventional therapy?
EMS providers administered naloxone 136 times in 2016; the state of Illinois mandates that all responders carry naloxone
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.